Meningococcal Vaccines and Herd Immunity: Lessons Learned From Serogroup C Conjugate Vaccination Programs
This article, published in Expert Review of Vaccines, reviews the herd immunity effects achieved following the introduction of meningococcal serogroup C conjugate (MCC) vaccines in the United Kingdom. The authors note that immunizing teenagers is crucial in maximizing indirect effects of vaccination. They also comment that herd immunity effects following vaccination with MCC could have important implications for the design and evaluation of new meningococcal vaccines, although questions remain about the duration of herd immunity protection. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Trotter CL, Maiden MC
Published: 2009
Visit web page (English)
(Located at www.ncbi.nlm.nih.gov)
Citation: Trotter CL, Maiden MC. Meningococcal Vaccines and Herd Immunity: Lessons Learned From Serogroup C Conjugate Vaccination Programs. Expert Review of Vaccines. 2009;8(7):851-861.
Resource types: Peer-reviewed journal
Diseases: Meningococcus
Topics: Disease burden and surveillance; Disease/vaccine specific information
Regions: North America and Europe

